TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SPS Pharma Solutions AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
62,000
|
57,119
|
54,807 |
| Financial expenses |
284
|
497
|
518 |
| Earnings before taxes |
6,163
|
-2,123
|
1,517 |
| EBITDA |
8,284
|
735
|
4,013 |
| Total assets |
61,101
|
57,410
|
49,151 |
| Current assets |
35,420
|
31,146
|
25,091 |
| Current liabilities |
16,144
|
19,585
|
17,409 |
| Equity capital |
39,813
|
36,244
|
29,713 |
| - share capital |
871
|
901
|
899 |
| Employees (average) |
306
|
322
|
312 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.2%
|
63.1%
|
60.5% |
| Turnover per employee |
203
|
177
|
176 |
| Profit as a percentage of turnover |
9.9%
|
-3.7%
|
2.8% |
| Return on assets (ROA) |
10.6%
|
-2.8%
|
4.1% |
| Current ratio |
219.4%
|
159.0%
|
144.1% |
| Return on equity (ROE) |
15.5%
|
-5.9%
|
5.1% |
| Change turnover |
6,823
|
2,153
|
11,866 |
| Change turnover % |
12%
|
4%
|
28% |
| Chg. No. of employees |
-16
|
10
|
34 |
| Chg. No. of employees % |
-5%
|
3%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.